Skip to content
Menu

UPDATE: Evogene Q3 EPS Cont Operations $(0.17) Beats $(0.19) Estimate

Benzinga Newsdesk 1 day ago

NewsEarningsEarnings BeatsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 37.04 percent increase over losses of $(0.27) per share from the same

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 37.04 percent increase over losses of $(0.27) per share from the same period last year.

Read at benzinga.com

← All stock news